Agilus Diagnostics
Agilus Diagnostics, a Fortis Healthcare subsidiary, operates India's largest diagnostic laboratory network (413 labs across 30+ states) offering 3,600+ pathology and radiology tests via walk-in, home collection, and digital channels.
- Company typePrivate
- Founded1995
- HeadquartersMohali, India
- Headcount—
- GTM typeB2B and B2C
- OfferingServices
What Agilus Diagnostics does
Agilus Diagnostics Limited, formerly SRL Diagnostics, is a wholly owned subsidiary of Fortis Healthcare and operates India's largest diagnostic laboratory network by number of laboratories, with 413 networking labs spanning 30+ states and union territories. Founded in 1995 and rebranded in 2023, Agilus runs the country's broadest accredited diagnostic footprint, including 40+ NABL-accredited labs and 2 CAP-accredited labs, and was the first Indian diagnostic chain to achieve both NABL (1999) and CAP (2002) accreditation.
The company offers more than 3,600 routine and specialized tests across pathology, radiology, molecular diagnostics, genetics, and immunology, delivered through walk-in labs, a pan-India home sample collection network, a franchise collection center program (Abhinandan), and digital channels including a mobile app and WhatsApp booking. Technology capabilities include the Illumina NovaSeq X next-generation sequencing platform at its Mumbai global reference laboratory and a partnership with Lucence for LiquidHALLMARK liquid biopsy-based cancer molecular testing. Service portfolio spans routine blood tests, advanced panels, imaging (X-ray, ultrasound, ECG, echocardiogram, mammography), and preventive health packages (Vital Care, Active Care, Premium Care, etc.).
Agilus operates on a fee-for-service, per-test pricing model with publicly listed test prices, serving individual consumers (direct-to-consumer via website/app/WhatsApp/home collection), hospitals and clinics (B2B referrals, primarily Fortis Healthcare), corporate wellness clients, and franchise partner operators. Revenue is transactional with no subscription model; pricing ranges from ₹350 (CBC) to ₹12,000+ for specialty panels, with package discounts and same-day routine test turnaround. Go-to-market combines direct-to-consumer digital acquisition, institutional field sales to hospitals and corporates, and franchise-led decentralized expansion, all integrated within Fortis Healthcare's broader hospital ecosystem.
Agilus Diagnostics firmographics
Firmographics- Name
- Agilus Diagnostics
- Legal name
- Agilus Diagnostics Ltd.
- Website
- https://agilusdiagnostics.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Short description
- Agilus Diagnostics, a Fortis Healthcare subsidiary, operates India's largest diagnostic laboratory network (413 labs across 30+ states) offering 3,600+ pathology and radiology tests via walk-in, home collection, and digital channels.
- Ownership category
- akta.pro rank
Agilus Diagnostics industry classification
Industry- Product category
- Diagnostic Laboratory Services
- NAICS
- Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN)
Keywords
Where Agilus Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Mohali
- HQ country
- India
- HQ region
- Asia
Offices4 records
Markets served
Agilus Diagnostics business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Diagnostic Testing Services (Fee-for-Service): Patients and healthcare providers pay per individual test or package. The company offers over 3,600 routine and specialized tests. Revenue is generated on a transactional basis from walk-in patients, home collection bookings, hospital referrals, and corporate/health check clients. No subscription model is described; pricing is per test or package with discounts available (e.g., 7% off on CBC).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Individual diagnostic tests sold at fixed per-test prices ranging from ₹350 to ₹12,000+ |
| Unit Pricing | Pay-as-you-go | Comprehensive health checkup packages at fixed package prices |
| Unit Pricing | Pay-as-you-go | Imaging and radiology services |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels6 records
Agilus Diagnostics product offering
Product offeringCore offering
Agilus Diagnostics provides diagnostic laboratory and radiology testing services across India through a network of 413 accredited labs and home sample collection. The company's core offering spans 3,600+ routine and specialized pathology tests, molecular diagnostics and genomics, advanced imaging, and preventive health checkup packages sold directly to consumers, hospitals, and corporate clients. Services are delivered through physical labs, a phlebotomist-driven home collection network, and digital booking channels (website, mobile app, WhatsApp).
Product overview
Agilus Diagnostics is India's largest diagnostic company by number of laboratories, operating 413 networking labs across 30+ states. Formerly known as SRL Diagnostics (renamed in 2023), the company offers a comprehensive diagnostic platform with 3,600+ routine and specialized tests spanning pathology, radiology, molecular diagnostics, genetics, and immunology. The portfolio includes core Agilus Diagnostics brand services, Agilus Care Packages (Vital Care, Active Care, Premium Care), health imaging services (Ultrasound, X-Ray, ECG, Mammography), and specialized offerings like molecular diagnostics and genetics. The company operates subsidiaries including Agilus Pathlabs Private Limited and DDRC Agilus Pathlabs, and provides digital access through its mobile app and eDOS test directory. Services are delivered through both walk-in labs and home collection options.
Differentiator
Problem solved
Functional benefit
Products and services
- Diagnostic Pathology and Radiology Tests Comprehensive routine and specialized pathology and radiology testing services including CBC, HbA1c, lipid profile, kidney and liver function tests, thyroid panels, infectious disease tests, and specialty assays, delivered through 413 accredited labs across India for individual patients, hospitals, and healthcare providers.
- Agilus Care Health Checkup Packages Pre-defined health checkup packages including Vital Care, Active Care, Active Pro, Premium Care, Diabetes & Heart Care, Vital Shape, Student Care, and Pre Marriage Care, offering comprehensive screening covering 90+ parameters for individual consumers and corporate wellness clients.
- Molecular Diagnostics and Genetic Testing
Quantifiable outcome
- Routine test results typically available within 24 hours
- +2 more outcomes
Companies that use Agilus Diagnostics
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles4 records
Agilus Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature4 records
Agilus Diagnostics partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor and core.
- Agilus Pathlabs Private LimitedminorIntra-group restructuring where Agilus Diagnostics Limited (parent) approved the merger of its wholly owned subsidiary Agilus Pathlabs Private Limited into itself, pending NCLT and creditor approvals. DDRC Agilus Pathlabs Limited is also being merged into Agilus Diagnostics.
- DDRC Agilus Pathlabs LimitedminorIntra-group restructuring where Agilus Diagnostics Limited (parent) approved the merger of its wholly owned subsidiary DDRC Agilus Pathlabs Limited into itself, pending NCLT and creditor approvals. Streamlines operations within the diagnostics segment without financial consideration.
- IlluminacoreAgilus Diagnostics installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory to expand India's next-generation sequencing capacity. The deployment enhances high-throughput genomic and multi-omic analysis capabilities for early disease detection and personalized treatment planning across clinical applications.
- LucencecoreAgilus Diagnostics and Lucence announced a strategic collaboration to integrate Lucence's molecular testing technologies into Agilus' laboratory network in India. The partnership enables Agilus to offer liquid biopsy-based screening for early cancer detection, recurrence monitoring, and therapy personalisation using Lucence's LiquidHALLMARK technology, expanding Agilus's advanced oncology offerings.
- Fortis HealthcarecoreAgilus Diagnostics is a wholly owned subsidiary of Fortis Healthcare. The diagnostic services are integrated into Fortis Healthcare's hospital operations across India, serving as the primary diagnostic laboratory partner for Fortis facilities. Fortis Healthcare is listed on Indian exchanges and is majority-owned by Malaysia's IHH Healthcare.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
Agilus Diagnostics competitors and assessment
Company assessmentDirect peers
- Thyrocare Technologies: Asset-light Indian diagnostics chain (acquired by PharmEasy) operating a centralized hub-and-spoke model. Comparable to Agilus in B2B preventive wellness category but competes on cost via a fundamentally different operating model.
- Apollo Diagnostics: Diagnostics arm of Apollo Hospitals, offering pathology, imaging, and home collection services. Direct peer to Agilus on hospital-anchored demand, full-service diagnostics, and integrated patient funnel.
- Dr. Lal PathLabs: India's largest listed diagnostics chain by market cap, offering routine and specialized pathology across a pan-India network of labs and collection centers. Closely comparable to Agilus in customer base, test menu breadth, NABL accreditation, and B2B hospital referral model.
- Metropolis Healthcare: Listed Indian diagnostics chain with extensive lab and service network across India and Africa, offering pathology and wellness testing. Directly comparable to Agilus on service mix, B2B/B2C hybrid model, and NABL-accredited laboratory footprint.
Emerging players
- Tata 1mg (Diagnostics): Digital-first health platform offering diagnostics booking, e-pharmacy, and teleconsultation. Comparable to Agilus on consumer-facing test booking, but operates asset-light aggregator model rather than owned labs.
- Neuberg Diagnostics: Pan-India diagnostics chain focused on advanced molecular and specialty testing. Comparable to Agilus in NGS/genomics expansion and NABL-accredited operations, but smaller scale.
- Orange Health Labs: Tech-enabled on-demand diagnostics startup offering home sample collection with rapid turnaround in major Indian metros. Competes with Agilus on home collection convenience and digital UX, despite smaller scale.
Regional players
- Vijaya Diagnostic Centre: South India-focused diagnostics chain with strong presence in Telangana and Andhra Pradesh. Comparable in service breadth and B2C health checkup packages, but with smaller national footprint than Agilus.
- Suburban Diagnostics: Western India (Maharashtra)-focused diagnostics chain with strong pathology and preventive health packages. Comparable to Agilus in regional B2C health checkup category and home collection model.
Broad incumbents
- Siemens Healthineers: Global medical technology leader supplying IVD analyzers, laboratory diagnostics equipment, and digital health platforms. Broadly comparable as a strategic partner/enabler in the diagnostics ecosystem in which Agilus operates.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Agilus Diagnostics social profiles
Digital presenceAgilus Diagnostics compliance and trust
Trust signalCompliance2 records
Agilus Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Agilus Diagnostics leadership team
Management profileNumber of profiles
Profiles6 records
Agilus Diagnostics subsidiaries and ownership
Company hierarchySubsidiaries3 records
Agilus Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Agilus Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Agilus Diagnostics
What does Agilus Diagnostics do?
Agilus Diagnostics provides diagnostic laboratory and radiology testing services across India through a network of 413 accredited labs and home sample collection. The company's core offering spans 3,600+ routine and specialized pathology tests, molecular diagnostics and genomics, advanced imaging, and preventive health checkup packages sold directly to consumers, hospitals, and corporate clients. Services are delivered through physical labs, a phlebotomist-driven home collection network, and digital booking channels (website, mobile app, WhatsApp).
Is Agilus Diagnostics a public or private company?
Agilus Diagnostics is a private company. It is classified as corporate owned and is currently operating.
When was Agilus Diagnostics founded?
Agilus Diagnostics was founded in 1995.
Where is Agilus Diagnostics based?
Agilus Diagnostics is headquartered in Mohali, India, in the Asia region.
How does Agilus Diagnostics make money?
One revenue line is on record: diagnostic Testing Services (Fee-for-Service).
Who are Agilus Diagnostics's main competitors?
Direct peers on record are Thyrocare Technologies, Apollo Diagnostics, Dr. Lal PathLabs and Metropolis Healthcare. Emerging players are Tata 1mg (Diagnostics), Neuberg Diagnostics and Orange Health Labs. Regional players are Vijaya Diagnostic Centre and Suburban Diagnostics. Siemens Healthineers is listed as a broad incumbent.
Does Agilus Diagnostics have an API?
No public API is recorded for Agilus Diagnostics.
What industry is Agilus Diagnostics in?
Agilus Diagnostics's product category is Diagnostic Laboratory Services. Its primary akta.pro industry code is HSABACAN, Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home). Its NAICS code is 62151 and its SIC code is 8071.